IMA
IMA
NASDAQ · Pharmaceuticals

Imagenebio Inc

$5.66
-0.36 (-5.98%)
As of May 9, 2:07 AM ET ·
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Buy 5 71%
Hold 1 14%
Sell 1 14%
Price Target
Analyst Price Target +112.4% upside
Low Target $8.98
Average Target $12.02
High Target $15.27
Current Price $5.66
Current
$5.66
Target
$12.02
$8.98 $12.02 avg $15.27
Scenario Analysis
Bear Case
$8.98
58.7%
Low target
Base Case
$12.02
+112.4%
Avg target
Bull Case
$15.27
+169.8%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$18.00
-68.6% from high
52-Week Low
$3.94
+43.7% from low
Target vs 52W High
$12.02
-33.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%